We can produce our own blood-derived, regenerative products, namely Platelet Rich Plasma (PRP) and Interleukin Receptor Antagonist Protein (IRAP) in our in-house laboratory. Both these products are obtained using gold-standard techniques and equipment.
PRP therapy is mostly used for tendon and ligament injuries; it is intended to support and enhance tissue healing. It can also be administered directly into joints.
PRP stands for platelet-rich plasma. In other words, out of a large sample of blood (we collect 60ml of blood from the jugular vein), we spin, separate, recollect and suspend platelets in a small volume of plasma, ready to be injected into a lesion.
Platelets contain a large quantity of growth factors. By concentrating them in a small volume and injecting them in a specific area we can deliver a potent stimulus to tissue regeneration and healing.
PRP is our treatment of choice following a tendon or a ligament injury (such as a core lesion to a flexor tendon or suspensory ligament). The whole procedure is performed at your premises. The platelet concentrate is injected directly into a tendon or ligament defect using ultrasound guidance for optimal accuracy.
This technique has been in use for a number of years and is increasingly popular.
It is regularly performed at your horse’s premises.
We can produce IRAP in our own lab by incubating centrifuged blood samples at an appropriate temperature, using specific blood tubes. We can produce 5 to 6 IRAP doses out of each blood-sample collection, which makes it quite cost effective and the even better news is that these can also be frozen and used at a later date.
IRAP has proven to be an effective treatment for lameness originating from a joint, especially if your horse is not responsive to routine corticosteroid injections.
It carries a very, very minimal risk of adverse reaction, and is an addition to other therapies for the treatment of lameness.
There is no withdrawal period for competition, since we are virtually re-injecting horse-specific, natural proteins.